Sanofi Consumer Healthcare India reports robust Q4 and FY’25 growth
For the fourth quarter, revenue surged 47% year-on-year to Rs. 2,510 million, driven by a 23% rise in domestic sales and a 9.3x jump in export sales
For the fourth quarter, revenue surged 47% year-on-year to Rs. 2,510 million, driven by a 23% rise in domestic sales and a 9.3x jump in export sales
The announcement follows a record-setting $1.2 million accelerated LineaDNA order
Operational leverage kicked in during the quarter, with adjusted EBITDA rising 21% year-on-year to Rs 147 crore
The company reported profit before tax of Rs.67 crore, up sharply from Rs.21 crore in the same period last year
The base Gland business posted ?11,790 million in revenue, up 16% YoY
Granules India has reported total income of Rs. 1,384.29 crore during the period ended December 31, 2025
The company’s consolidated revenue from operations rose to Rs. 361.13 crore in Q2 FY26 and Rs. 707.67 crore for the first half
Solventum aims to accelerate innovation in acute wound care, expand its market reach, and deliver enhanced solutions for patients, clinicians, and shareholders
Consolidated revenue from operations stood at Rs. 111.05 crore
Newly commissioned MCC in Jhagadia and Dahej and CCS project expansions will unlock an additional 8,800 MTPA, fuelling year-over-year revenue gains of 20%-30% in excipients
Subscribe To Our Newsletter & Stay Updated